| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 6 | +83.33% | -3.96% | -1.21% | -2.75% | -3.12% | — |
| 14d | 6 | +100.00% | -5.85% | -2.15% | -3.70% | -5.32% | — |
| 30d | 6 | +83.33% | -7.37% | -2.93% | -4.44% | -3.97% | — |
| 60d | 6 | +83.33% | -5.88% | -1.52% | -4.35% | -3.38% | — |
| 90d | 6 | +33.33% | +3.88% | +0.90% | +3.27% | +2.48% | — |
| 180d | 6(1 pending) | +20.00% | +26.87% | +8.24% | +18.63% | +17.00% | — |
| 1y | 6(1 pending) | +20.00% | +56.92% | +15.40% | +41.53% | +58.13% | — |
| 2y | 6(3 pending) | +0.00% | +91.39% | +39.16% | +52.24% | +38.67% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE10b5-1 10b5-1 plan | 106,563 | $34.10 | $3.63M | 65,621 | Jun 11, 2026 | Jun 16, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE10b5-1 10b5-1 plan | 153,251 | $35.61 | $5.46M | 172,184 | May 14, 2026 | May 18, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 19,916 | — | — | 59,748 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 19,916 | — | — | 325,435 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 23,251 | — | — | 46,503 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 33,512 | — | — | 282,268 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 53,175 | — | — | 53,175 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 33,512 | — | — | 0 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 23,251 | — | — | 305,519 | Mar 4, 2026 | Mar 6, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 49,800 | — | — | 49,802 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 49,800 | — | — | 107,278 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 141,478 | — | — | 248,756 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 141,478 | — | — | 0 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE10b5-1 10b5-1 plan | 345,810 | $33.64 | $11.63M | 57,478 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 141,478 | — | — | 141,478 | Jan 27, 2026 | Jan 29, 2026 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE10b5-1 10b5-1 plan | 55,775 | $17.08 | $952.5K | 403,288 | Jun 12, 2025 | Jun 16, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 21,390 | — | — | 0 | Mar 5, 2025 | Mar 7, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 21,390 | — | — | 459,063 | Mar 5, 2025 | Mar 7, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 79,664 | — | — | 79,664 | Mar 5, 2025 | Mar 7, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 23,251 | — | — | 69,754 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 183,169 | — | — | 437,673 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 33,512 | — | — | 33,512 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 33,512 | — | — | 231,253 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 23,251 | — | — | 254,504 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 183,169 | — | — | 0 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 49,800 | — | — | 99,602 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 49,800 | — | — | 197,741 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE10b5-1 10b5-1 plan | 55,750 | $16.21 | $903.5K | 147,941 | Feb 28, 2025 | Mar 4, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 183,169 | — | — | 183,169 | Jan 28, 2025 | Jan 30, 2025 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE10b5-1 10b5-1 plan | 77,550 | $13.52 | $1.05M | 203,691 | Mar 6, 2024 | Mar 7, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 21,387 | — | — | 281,241 | Mar 5, 2024 | Mar 7, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 52,320 | — | — | 259,854 | Mar 5, 2024 | Mar 7, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 21,387 | — | — | 21,390 | Mar 5, 2024 | Mar 7, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 52,320 | — | — | 0 | Mar 5, 2024 | Mar 7, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 33,512 | — | — | 207,534 | Mar 4, 2024 | Mar 5, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 93,005 | — | — | 93,005 | Mar 4, 2024 | Mar 5, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 33,512 | — | — | 207,534 | Mar 4, 2024 | Mar 5, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 49,800 | — | — | 174,022 | Mar 3, 2024 | Mar 5, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 49,800 | — | — | 174,022 | Mar 3, 2024 | Mar 5, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 18,430 | — | — | 124,222 | Feb 28, 2024 | Mar 1, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 18,430 | — | — | 0 | Feb 28, 2024 | Mar 1, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 6,630 | — | — | 0 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 6,630 | — | — | 105,792 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 52,320 | — | — | 52,320 | Jan 30, 2024 | Feb 1, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 35,125 | $9.73 | $341.9K | 99,162 | Aug 7, 2023 | Aug 9, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 21,387 | — | — | 42,777 | Mar 5, 2023 | Mar 7, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 21,387 | — | — | 134,287 | Mar 5, 2023 | Mar 7, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 33,512 | — | — | 112,900 | Mar 4, 2023 | Mar 7, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 33,512 | — | — | 100,536 | Mar 4, 2023 | Mar 7, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 199,202 | — | — | 199,202 | Mar 3, 2023 | Mar 7, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 44,953 | — | — | 0 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 44,953 | — | — | 79,388 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 18,430 | — | — | 34,435 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 18,430 | — | — | 18,430 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 6,629 | — | — | 16,005 | Feb 13, 2023 | Feb 15, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 6,629 | — | — | 6,630 | Feb 13, 2023 | Feb 15, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 44,953 | — | — | 44,953 | Feb 7, 2023 | Feb 9, 2023 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 55,500 | $10.07 | $558.7K | 9,376 | Aug 22, 2022 | Aug 24, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 21,387 | — | — | 64,876 | Mar 5, 2022 | Mar 8, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 21,387 | — | — | 64,164 | Mar 5, 2022 | Mar 8, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 134,048 | — | — | 134,048 | Mar 4, 2022 | Mar 8, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 18,430 | — | — | 36,860 | Feb 28, 2022 | Mar 2, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 18,430 | — | — | 43,489 | Feb 28, 2022 | Mar 2, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 6,629 | — | — | 13,259 | Feb 13, 2022 | Feb 15, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 6,629 | — | — | 25,059 | Feb 13, 2022 | Feb 15, 2022 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 85,551 | — | — | 85,551 | Mar 5, 2021 | Mar 8, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, Chief Financial Officer | 18,430 | — | — | 55,290 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, Chief Financial Officer | 18,430 | — | — | 18,430 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 73,720 | — | — | 73,720 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 19,888 | — | — | 19,888 | Feb 13, 2020 | Feb 18, 2020 ↗ | View → |